Noxopharm Limited (NOXOF)
USD 0.05
(0.0%)
USD 0.05
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -684.31 Thousand | -10.94 Million | -13.73 Million | -8.85 Million | -11.13 Million | -9.77 Million |
| Net Income | -3.57 Million | -15.05 Million | -18.66 Million | -9.34 Million | -272.09 Thousand | -11.22 Million |
| Depreciation & Amortization | 1743.00 | 154.53 Thousand | 261.51 Thousand | 261.72 Thousand | 241.44 Thousand | 62.09 Thousand |
| Deferred income taxes | - | -11.69 Thousand | -803.51 Thousand | -1.74 Million | -311.6 Thousand | -899.14 Thousand |
| Stock-based compensation | - | 11.69 Thousand | 803.51 Thousand | 1.74 Million | 311.6 Thousand | 899.14 Thousand |
| Change in working capital | 3.73 Million | -590.94 Thousand | -5.07 Million | 3.6 Million | -3.62 Million | 1.18 Million |
| Other non-cash items | -842.67 Thousand | 4.54 Million | 9.74 Million | -3.36 Million | -7.48 Million | 202.34 Thousand |
| Investing Cash Flow | - | 123.51 Thousand | - | 225.23 Thousand | 337.81 Thousand | -3201.00 |
| Investments in PPE | - | - | - | - | -3000.00 | -6397.00 |
| Acquisitions | - | - | - | - | 340.81 Thousand | 3196.00 |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | 123.51 Thousand | - | - | - | - |
| Other Investing Activities | - | 123.51 Thousand | - | 225.23 Thousand | 340.81 Thousand | 3196.00 |
| Financing Cash Flow | - | -178.09 Thousand | 975.72 Thousand | 28.32 Million | 14.99 Million | 75 Thousand |
| Debt repayment | -2 Million | -178.09 Thousand | -229.14 Thousand | -244.82 Thousand | -4.11 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -1.52 Million | -785.68 Thousand | - |
| Common Stock Issuance | - | - | 1.2 Million | 28.56 Million | 10.22 Million | 75 Thousand |
| Other Financing Activities | -2 Million | -178.09 Thousand | -229.14 Thousand | 1.28 Million | 10.18 Million | 75 Thousand |
| Accounts receivables | 3.7 Million | -477.43 Thousand | 176.66 Thousand | -1.13 Million | -4.72 Million | -37.75 Thousand |
| Accounts payables | - | -1.07 Million | -4.33 Million | 4.34 Million | 767.48 Thousand | 600.15 Thousand |
| Inventory | - | 1.14 Million | -834.98 Thousand | 207.72 Thousand | 177.17 Thousand | 572.61 Thousand |
| Other working capital | 32.76 Thousand | -181.26 Thousand | -78.39 Thousand | 190.42 Thousand | 151.38 Thousand | 47.57 Thousand |
| Cash at beginning of period | 3 Million | 14.01 Million | 26.79 Million | 7.1 Million | 2.9 Million | 12.61 Million |
| Cash at end of period | 2.31 Million | 3 Million | 14.01 Million | 26.79 Million | 7.1 Million | 2.9 Million |
| Capital Expenditure | - | - | - | - | -3000.00 | -6397.00 |
| Effect of forex changes on cash | -4437.00 | -1066.00 | -27.31 Thousand | -3697.00 | - | - |
| Net cash flow / Change in cash | -688.74 Thousand | -11 Million | -12.78 Million | 19.69 Million | 4.19 Million | -9.7 Million |
| Free Cash Flow | -684.31 Thousand | -10.94 Million | -13.73 Million | -8.85 Million | -11.14 Million | -9.78 Million |
| Breakdown | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -540.09 Thousand | -540.09 Thousand | -1.24 Million | -1.24 Million | -15.05 Million | -9.62 Million |
| Depreciation & Amortization | 434.00 | 434.00 | 438.00 | 438.00 | 154.53 Thousand | 11.04 Thousand |
| Deferred income taxes | - | - | - | - | -11.69 Thousand | -271.82 Thousand |
| Stock-based compensation | - | - | - | - | 11.69 Thousand | 5845.00 |
| Change in working capital | 1.86 Million | 1.86 Million | - | - | -590.94 Thousand | 243.89 Thousand |
| Other non-cash items | -2.73 Million | -2.73 Million | 2.31 Million | 2.31 Million | 4.54 Million | 1.39 Million |
| Investing Cash Flow | - | - | - | - | 123.51 Thousand | 123.51 Thousand |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | 123.51 Thousand | - |
| Other Investing Activities | - | - | - | - | 123.51 Thousand | 123.51 Thousand |
| Financing Cash Flow | - | - | - | - | -178.09 Thousand | -19.74 Thousand |
| Debt repayment | - | - | - | - | -178.09 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | -178.09 Thousand | -9875.00 |
| Accounts receivables | 1.85 Million | 1.85 Million | - | - | -477.43 Thousand | -238.71 Thousand |
| Accounts payables | - | - | - | - | -1.07 Million | - |
| Inventory | - | - | - | - | 1.14 Million | 573.24 Thousand |
| Other working capital | 16.38 Thousand | 16.38 Thousand | - | - | -181.26 Thousand | -90.63 Thousand |
| Cash at beginning of period | - | - | - | - | 14.01 Million | 11.12 Million |
| Cash at end of period | -1.41 Million | -1.41 Million | 1.07 Million | 1.07 Million | 3 Million | 3 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | -7112.00 | -7112.00 | 4893.00 | 4893.00 | -1066.00 | -1675.00 |
| Net cash flow / Change in cash | -1.41 Million | -1.41 Million | 1.07 Million | 1.07 Million | -11 Million | -8.11 Million |
| Free Cash Flow | -1.41 Million | -1.41 Million | 1.06 Million | 1.06 Million | -10.94 Million | -8.24 Million |
CHOLAFIN
1882
4491
GRBK
0636
IFSPF